Sermorelin
Also known as: GRF 1-29, GHRH 1-29, Geref
Overview
Sermorelin is a synthetic 29-amino acid peptide that represents the shortest fully functional fragment of endogenous growth hormone-releasing hormone (GHRH). It was FDA-approved as a diagnostic agent and later as a therapeutic for GH deficiency in children. Sermorelin's mechanism closely mimics the natural pulsatile GHRH release cycle, preserving the physiological negative feedback loop and making it a preferred choice in anti-aging and hormone optimization protocols.
Mechanism of Action
Sermorelin binds to GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and secretion in a pattern that mirrors endogenous GHRH pulses. This pulsatile release maintains receptor sensitivity and avoids the desensitization associated with exogenous GH administration. Studies show it can double GH levels for up to 12 hours after injection, with peak levels around 2 hours. Half-life is approximately 11-12 minutes, resulting in a sharp physiological pulse.
Potential Benefits
- Preserves physiological pulsatile GH release pattern
- Supports natural negative feedback loop, reducing risk of pituitary suppression
- Improved body composition, lean mass, and fat reduction
- Enhanced sleep quality, particularly deep sleep stages
- Improved energy levels and recovery
- Anti-aging effects via GH/IGF-1 axis
- FDA historical approval provides established safety data
Dosage Protocols
The following reflects doses used in published research studies. This is not medical advice. Consult a qualified healthcare professional.
| Typical Range | 200-500 mcg/day |
| Beginner | 200-250 mcg at bedtime |
| Intermediate | 500 mcg at bedtime |
| Advanced | 500 mcg twice daily (bedtime + AM fasted) |
| Cycle Duration | 3-6 months continuous |
| Cycle Off | 1-2 months; may rotate with CJC-1295 |
Best dosed at bedtime on an empty stomach to amplify the physiological nocturnal GH pulse. Short half-life (~11 min) preserves natural pulsatility. Often prescribed in physician-supervised anti-aging protocols.
Use our Reconstitution Calculator to determine exact syringe units for your protocol.
Routes of Administration
Subcutaneous Injection High
Standard clinical and research route; bedtime dosing recommended
Sublingual Moderate
Compounded sublingual preparations available; lower bioavailability than injection but needle-free alternative for some patients
Read our full Routes of Administration Guide for detailed comparison of all delivery methods.
Stacking Protocols
Popular research stacks involving Sermorelin:
Classic GHRH+GHRP Stack
Physiological GH pulse optimization
Sermorelin provides the GHRH signal while Ipamorelin amplifies the pituitary response; similar to CJC-1295/Ipamorelin but with shorter, more physiological action.
Anti-Aging Foundation Stack
GH axis restoration with telomere and tissue repair support
Well-tolerated, physician-prescribed anti-aging stack suitable for long-term use.
Explore our complete Peptide Stacking Guide for more combinations and safety considerations.
Reconstitution
| Typical Vial Size | 3mg, 6mg, 9mg |
|---|---|
| BAC Water | 1ml per 3mg vial (yields 3000 mcg/ml) |
| Storage | Refrigerate at 2-8°C after reconstitution; discard unused portion after 30 days |
| Shelf Life | 30 days refrigerated; lyophilized stable at -20°C for 24+ months |
Need exact syringe measurements?
Amino Acid Sequence
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Side Effects & Safety
- Mild headache
- Flushing
- Injection site reactions
- Possible water retention at high doses
- Nausea (uncommon)
Synergistic Compounds
The following compounds have been studied alongside Sermorelin for potential complementary or synergistic effects:
Learn More
References & Further Reading
- [object Object]
- [object Object]